[VSsupport]

<img alt="" height="1" width="1" />Sucampo Pharmaceuticals Reports Full Year and Fourth Quarter 2009 Financial ...MarketWatch (press release)Amitiza(R) is currently the only FDA-approved therapy for either chronic idiopathic constipation, or CIC, in adults or irritable bowel syndrome with ...<nobr>and more »</nobr>

View the full article